Correction: Yadav et al. PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression. Pharmaceutics 2022, 14, 1326
Additional Affiliation
Addition of Two Authors
Addition of Acknowledgement
Reference
- Yadav, N.; Tripathi, A.K.; Parveen, A.; Parveen, S.; Banerjee, M. PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression. Pharmaceutics 2022, 14, 1326. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Yadav, N.; Tripathi, A.K.; Parveen, A.; Parveen, S.; Banerjee, M. Correction: Yadav et al. PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression. Pharmaceutics 2022, 14, 1326. Pharmaceutics 2024, 16, 124. https://doi.org/10.3390/pharmaceutics16010124
Yadav N, Tripathi AK, Parveen A, Parveen S, Banerjee M. Correction: Yadav et al. PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression. Pharmaceutics 2022, 14, 1326. Pharmaceutics. 2024; 16(1):124. https://doi.org/10.3390/pharmaceutics16010124
Chicago/Turabian StyleYadav, Neera, Amit Kumar Tripathi, Amna Parveen, Shama Parveen, and Monisha Banerjee. 2024. "Correction: Yadav et al. PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression. Pharmaceutics 2022, 14, 1326" Pharmaceutics 16, no. 1: 124. https://doi.org/10.3390/pharmaceutics16010124
APA StyleYadav, N., Tripathi, A. K., Parveen, A., Parveen, S., & Banerjee, M. (2024). Correction: Yadav et al. PLGA-Quercetin Nano-Formulation Inhibits Cancer Progression via Mitochondrial Dependent Caspase-3,7 and Independent FoxO1 Activation with Concomitant PI3K/AKT Suppression. Pharmaceutics 2022, 14, 1326. Pharmaceutics, 16(1), 124. https://doi.org/10.3390/pharmaceutics16010124